Pulmonx Corp
NASDAQ:LUNG
P/E
Price to Earnings
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
Market Cap | P/E | ||||
---|---|---|---|---|---|
US |
Pulmonx Corp
NASDAQ:LUNG
|
341.9m USD | -5.8 | ||
JP |
Hoya Corp
TSE:7741
|
6.4T JPY | 38.2 | ||
CH |
Alcon AG
SIX:ALC
|
36.1B CHF | 40.8 | ||
DK |
Coloplast A/S
CSE:COLO B
|
189.1B DKK | 38.9 | ||
US |
Align Technology Inc
NASDAQ:ALGN
|
20.3B USD | 44 | ||
US |
Cooper Companies Inc
NYSE:COO
|
18.3B USD | 63 | ||
KR |
H
|
HLB Inc
KOSDAQ:028300
|
13.9T KRW | -73.4 | |
CN |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
61.5B CNY | 37.2 | ||
UK |
ConvaTec Group PLC
LSE:CTEC
|
5.3B GBP | 51.1 | ||
US |
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
5.8B USD | -60.6 | ||
US |
Lantheus Holdings Inc
NASDAQ:LNTH
|
5.2B USD | 11.2 |
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.